SRZNW
Surrozen, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−60.53%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-91.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Feb 18, 2026 | Li Yang · officer: Exec. Vice President, Research | A-Award | 100,950 | $0.00 |
| Feb 18, 2026 | Williams Charles O · officer: Chief Operating Officer | A-Award | 102,900 | $0.00 |
| Feb 18, 2026 | Parker Craig C · director, officer: Chief Executive Officer | A-Award | 242,200 | $25 |
| Feb 13, 2026 | TCG Crossover GP II, LLC · 10 percent owner | Purchase | 547 | $24 |
| Feb 13, 2026 | TCG Crossover GP II, LLC · 10 percent owner | Purchase | 546 | $24 |
| Feb 13, 2026 | TCG Crossover GP II, LLC · 10 percent owner | Purchase | 8,882 | $24 |
| Feb 13, 2026 | TCG Crossover GP II, LLC · 10 percent owner | Purchase | 8,881 | $24 |
| Feb 3, 2026 | TCG Crossover GP II, LLC · 10 percent owner | Purchase | 2,178 | $22 |
| Feb 3, 2026 | TCG Crossover GP II, LLC · 10 percent owner | Purchase | 2,177 | $22 |
| Feb 3, 2026 | TCG Crossover GP II, LLC · 10 percent owner | Purchase | 366 | $21 |
| Feb 3, 2026 | TCG Crossover GP II, LLC · 10 percent owner | Purchase | 365 | $21 |
| Feb 3, 2026 | TCG Crossover GP II, LLC · 10 percent owner | Purchase | 2,136 | $21 |
| Feb 3, 2026 | TCG Crossover GP II, LLC · 10 percent owner | Purchase | 2,135 | $21 |
| Jan 26, 2026 | Williams Charles O · officer: Chief Operating Officer | A-Award | 500 | $20 |
| Jan 20, 2026 | COLUMN GROUP III GP, LP · 10 percent owner | Purchase | 9,568 | $20 |
| Jan 20, 2026 | COLUMN GROUP III GP, LP · 10 percent owner | Purchase | 1,358 | $20 |
| Jan 20, 2026 | COLUMN GROUP III GP, LP · 10 percent owner | Purchase | 6,303 | $20 |
| Jan 20, 2026 | COLUMN GROUP III GP, LP · 10 percent owner | Purchase | 8,484 | $20 |
| Jan 20, 2026 | COLUMN GROUP III GP, LP · 10 percent owner | Purchase | 1,204 | $20 |
| Jan 20, 2026 | COLUMN GROUP III GP, LP · 10 percent owner | Purchase | 5,590 | $20 |
| Jan 20, 2026 | Kutzkey Tim · director, 10 percent owner: | Purchase | 9,568 | $20 |
| Jan 20, 2026 | Kutzkey Tim · director, 10 percent owner: | Purchase | 1,358 | $20 |
| Jan 20, 2026 | Kutzkey Tim · director, 10 percent owner: | Purchase | 6,303 | $20 |
| Jan 20, 2026 | Kutzkey Tim · director, 10 percent owner: | Purchase | 8,484 | $20 |
| Jan 20, 2026 | Kutzkey Tim · director, 10 percent owner: | Purchase | 1,204 | $20 |
| Jan 20, 2026 | Kutzkey Tim · director, 10 percent owner: | Purchase | 5,590 | $20 |
| Jan 15, 2026 | Kutzkey Tim · director, 10 percent owner: | Purchase | 2,927 | $20 |
| Jan 15, 2026 | Kutzkey Tim · director, 10 percent owner: | Purchase | 6,609 | $20 |
| Jan 15, 2026 | Kutzkey Tim · director, 10 percent owner: | Purchase | 2,596 | $20 |
| Jan 15, 2026 | Kutzkey Tim · director, 10 percent owner: | Purchase | 5,861 | $20 |
Institutional positioning
13F filings over the trailing two quarters
New 1Increased 3Reduced 0Sold out 18
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | Unchanged | 833,333 | May 15, 2026 |
| LMR PARTNERS LLP | Unchanged | 648,285 | May 15, 2026 |
| BRIDGER MANAGEMENT, LLC | Unchanged | 442,052 | May 15, 2026 |
| EUCLIDEAN CAPITAL LLC | Unchanged | 170,833 | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Unchanged | 166,666 | May 29, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Unchanged | 166,666 | May 15, 2026 |
| SymBiosis Capital Partners, LLC | Unchanged | 150,000 | May 12, 2026 |
| ARROWMARK COLORADO HOLDINGS LLC | Unchanged | 108,333 | May 15, 2026 |
| CITIGROUP INC | Unchanged | 106,909 | May 11, 2026 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | Unchanged | 83,333 | May 28, 2026 |
| MILLENNIUM MANAGEMENT LLC | Unchanged | 73,900 | May 15, 2026 |
| BOXER CAPITAL MANAGEMENT, LLC | Unchanged | 66,666 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | New Position | 41,666 | May 15, 2026 |
| TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | Unchanged | 33,333 | May 15, 2026 |
| Virtu Financial LLC | Increased | 11,071 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 18, 2026